Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Alfaxolone
2. Alphaxalone
3. Alphaxalone, (3alpha)-isomer
4. Alphaxalone, (3alpha,5beta)-isomer
5. Alphaxalone, (3beta,5alpha)-isomer
6. Alphaxalone, (3beta,5beta)-isomer
7. Delta(16)-alfaxalone
8. Hydroxy-5 Alpha-pregnane-11,20-dione
1. Alphaxalone
2. 23930-19-0
3. 5alpha-pregnan-3alpha-ol-11,20-dione
4. Alfaxalonum [inn-latin]
5. Alfaxalona [inn-spanish]
6. Gr 2/234
7. Phaxan
8. 3alpha-hydroxy-5alpha-pregnane-11,20-dione
9. (3r,5s,8s,9s,10s,13s,14s,17s)-17-acetyl-3-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-11-one
10. Alfadione
11. Mls000069684
12. Mls001076262
13. Bd07m97b2a
14. Chembl190279
15. Chebi:34531
16. Alfaxalone (inn)
17. Ncgc00023100-03
18. Smr000058494
19. (3a,5a)-3-hydroxypregnane-11,20-dione
20. Alfaxalone [inn]
21. Dsstox_cid_2576
22. Dsstox_rid_76638
23. Alphaxolone
24. Dsstox_gsid_22576
25. Alfaxalona
26. Alfaxalonum
27. Sr-01000000168
28. Brn 3217240
29. Unii-bd07m97b2a
30. 3alpha-hydroxy-5alpha-pregnan-11,20-dion
31. 5alpha-alphaxalone
32. Alfaxalone [inn:ban:dcf:jan]
33. 3-alpha-hydroxy-5-alpha-pregnane-11,20-dione
34. (3-alpha,5-alpha)-3-hydroxypregnane-11,20-dione
35. Cas-23930-19-0
36. Alfaxalone [mi]
37. 3.alpha.-hydroxy-5.alpha.-pregnane-11,20-dione
38. Alfaxalone [jan]
39. Opera_id_1629
40. Prestwick0_001002
41. Prestwick1_001002
42. Prestwick2_001002
43. Prestwick3_001002
44. Alfaxalone [mart.]
45. Alfaxalone [who-dd]
46. (3alpha,5alpha)-3-hydroxypregnane-11,20-dione
47. Bidd:pxr0037
48. Lopac0_000929
49. Pregnane-11,20-dione, 3-hydroxy-, (3a,5a)-
50. Schembl57756
51. Bspbio_001123
52. 4-08-00-02091 (beilstein Handbook Reference)
53. 5-alpha-pregnane-11,20-dione, 3-alpha-hydroxy-
54. Spbio_003004
55. Bpbio1_001237
56. Gtpl5461
57. Alfaxalone [green Book]
58. Dtxsid9022576
59. Pregnane-11,20-dione, 3-hydroxy-, (3-alpha,5-alpha)-
60. Hms1571i05
61. Hms2098i05
62. Hms2236n05
63. Hms3262j20
64. Hms3715i05
65. Zinc4081122
66. Tox21_110884
67. Tox21_500929
68. Bdbm50164570
69. Akos024457399
70. Tox21_110884_1
71. Ccg-205010
72. Db11371
73. Lp00929
74. Sdccgsbi-0050903.p002
75. 5alpha-pregnane-3alpha-ol-11,20-dione
76. Ncgc00023100-04
77. Ncgc00023100-05
78. Ncgc00023100-06
79. Ncgc00023100-08
80. Ncgc00261614-01
81. Gr-2/234
82. (3?,5?)-3-hydroxypregnane-11,20-dione
83. Ab00384358
84. B7253
85. Eu-0100929
86. D07282
87. P 5052
88. Sr-01000076070
89. J-015280
90. Q3611058
91. Sr-01000000168-2
92. Sr-01000000168-3
93. Sr-01000076070-1
94. Brd-k41445866-001-03-0
95. 5alpha-pregnan-3alpha-ol-11,20-dione, Powder, >=98% (tlc)
96. (3beta,5alpha,8alpha,9beta,10alpha)-3-hydroxypregnane-11,20-dione
97. (3r,5s,8s,9s,10s,13s,14s,17s)-17-acetyl-3-hydroxy-10,13-dimethyl-hexadecahydro-cyclopenta[a]phenanthren-11-one
98. Ey4
| Molecular Weight | 332.5 g/mol |
|---|---|
| Molecular Formula | C21H32O3 |
| XLogP3 | 3.2 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 1 |
| Exact Mass | 332.23514488 g/mol |
| Monoisotopic Mass | 332.23514488 g/mol |
| Topological Polar Surface Area | 54.4 Ų |
| Heavy Atom Count | 24 |
| Formal Charge | 0 |
| Complexity | 569 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 8 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Neurosteroids
Endogenous compounds or drugs that affect neuronal excitability through modulation of specific ionotropic receptors (e.g., GABA-A RECEPTORS). Endogenous neurosteroids are steroid hormones de novo synthesized by neurons and glial cells from steroid metabolite precursors (e.g., PREGNENOLONE). (See all compounds classified as Neurosteroids.)
Anesthetics
Agents capable of inducing a total or partial loss of sensation, especially tactile sensation and pain. They may act to induce general ANESTHESIA, in which an unconscious state is achieved, or may act locally to induce numbness or lack of sensation at a targeted site. (See all compounds classified as Anesthetics.)
N - Nervous system
N01 - Anesthetics
N01A - Anesthetics, general
N01AX - Other general anesthetics
N01AX05 - Alfaxalone
Related Excipient Companies
Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients by Applications
Parenteral
Solubilizers
Taste Masking
Thickeners and Stabilizers
Topical
Controlled & Modified Release
Market Place
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
A Alfaxalone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Alfaxalone, including repackagers and relabelers. The FDA regulates Alfaxalone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Alfaxalone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Alfaxalone manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Alfaxalone supplier is an individual or a company that provides Alfaxalone active pharmaceutical ingredient (API) or Alfaxalone finished formulations upon request. The Alfaxalone suppliers may include Alfaxalone API manufacturers, exporters, distributors and traders.
click here to find a list of Alfaxalone suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Alfaxalone Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Alfaxalone GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Alfaxalone GMP manufacturer or Alfaxalone GMP API supplier for your needs.
A Alfaxalone CoA (Certificate of Analysis) is a formal document that attests to Alfaxalone's compliance with Alfaxalone specifications and serves as a tool for batch-level quality control.
Alfaxalone CoA mostly includes findings from lab analyses of a specific batch. For each Alfaxalone CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Alfaxalone may be tested according to a variety of international standards, such as European Pharmacopoeia (Alfaxalone EP), Alfaxalone JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Alfaxalone USP).
LOOKING FOR A SUPPLIER?
